Annual ROA
-30.24%
+6.75%+18.25%
31 December 2023
Summary:
Editas Medicine annual return on assets is currently -30.24%, with the most recent change of +6.75% (+18.25%) on 31 December 2023. During the last 3 years, it has fallen by -8.79% (-40.98%). EDIT annual ROA is now -40.98% below its all-time high of -21.45%, reached on 31 December 2020.EDIT ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-48.82%
-8.02%-19.66%
30 September 2024
Summary:
Editas Medicine quarterly return on assets is currently -48.82%, with the most recent change of -8.02% (-19.66%) on 30 September 2024. Over the past year, it has dropped by -10.66% (-27.94%). EDIT quarterly ROA is now -178.34% below its all-time high of -17.54%, reached on 30 September 2020.EDIT Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.3% | -27.9% |
| 3 y3 years | -41.0% | -56.5% |
| 5 y5 years | -9.1% | -54.5% |
EDIT ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.0% | +18.3% | -86.3% | at low |
| 5 y | 5 years | -41.0% | +18.3% | -178.3% | at low |
| alltime | all time | -41.0% | +73.1% | -178.3% | +89.8% |
Editas Medicine ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -48.82%(+19.7%) |
| June 2024 | - | -40.80%(+20.4%) |
| Mar 2024 | - | -33.90%(+11.7%) |
| Dec 2023 | -30.24%(-18.2%) | -30.35%(-20.5%) |
| Sept 2023 | - | -38.16%(-2.4%) |
| June 2023 | - | -39.09%(-3.1%) |
| Mar 2023 | - | -40.35%(+7.1%) |
| Dec 2022 | -36.99%(+20.1%) | -37.66%(+17.2%) |
| Sept 2022 | - | -32.13%(+16.8%) |
| June 2022 | - | -27.50%(+4.9%) |
| Mar 2022 | - | -26.21%(-4.6%) |
| Dec 2021 | -30.80%(+43.6%) | -27.47%(-12.0%) |
| Sept 2021 | - | -31.20%(+25.9%) |
| June 2021 | - | -24.79%(+12.8%) |
| Mar 2021 | - | -21.97%(+6.1%) |
| Dec 2020 | -21.45%(-25.5%) | -20.70%(+18.0%) |
| Sept 2020 | - | -17.54%(-37.3%) |
| June 2020 | - | -27.98%(-18.1%) |
| Mar 2020 | - | -34.15%(+4.0%) |
| Dec 2019 | -28.79% | -32.84%(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -31.60%(+18.4%) |
| June 2019 | - | -26.68%(-2.2%) |
| Mar 2019 | - | -27.28%(-1.8%) |
| Dec 2018 | -27.71%(-30.6%) | -27.78%(-12.9%) |
| Sept 2018 | - | -31.91%(-9.5%) |
| June 2018 | - | -35.25%(+10.3%) |
| Mar 2018 | - | -31.95%(-9.4%) |
| Dec 2017 | -39.95%(-22.2%) | -35.28%(-10.1%) |
| Sept 2017 | - | -39.23%(-1.2%) |
| June 2017 | - | -39.71%(-2.0%) |
| Mar 2017 | - | -40.50%(-6.7%) |
| Dec 2016 | -51.35%(+5.2%) | -43.42%(+29.4%) |
| Sept 2016 | - | -33.55%(+19.2%) |
| June 2016 | - | -28.15%(-38.7%) |
| Mar 2016 | - | -45.90%(-2.7%) |
| Dec 2015 | -48.81%(-56.5%) | -47.17%(-38.3%) |
| Sept 2015 | - | -76.40%(-84.0%) |
| June 2015 | - | -478.12%(+444.5%) |
| Mar 2015 | - | -87.81%(+97.8%) |
| Dec 2014 | -112.28% | -44.40% |
FAQ
- What is Editas Medicine annual return on assets?
- What is the all time high annual ROA for Editas Medicine?
- What is Editas Medicine annual ROA year-on-year change?
- What is Editas Medicine quarterly return on assets?
- What is the all time high quarterly ROA for Editas Medicine?
- What is Editas Medicine quarterly ROA year-on-year change?
What is Editas Medicine annual return on assets?
The current annual ROA of EDIT is -30.24%
What is the all time high annual ROA for Editas Medicine?
Editas Medicine all-time high annual return on assets is -21.45%
What is Editas Medicine annual ROA year-on-year change?
Over the past year, EDIT annual return on assets has changed by +6.75% (+18.25%)
What is Editas Medicine quarterly return on assets?
The current quarterly ROA of EDIT is -48.82%
What is the all time high quarterly ROA for Editas Medicine?
Editas Medicine all-time high quarterly return on assets is -17.54%
What is Editas Medicine quarterly ROA year-on-year change?
Over the past year, EDIT quarterly return on assets has changed by -10.66% (-27.94%)